Impact of timing of pregnancy and genetic risk on local therapy choices for young women with breast cancer

By sjmartinez • November 6, 2024

Lipsyc-Sharf M, Huang M, Huang SY, Suresh YK, Doll A, Baker JL, Kapoor NS. Impact of timing of pregnancy and genetic risk on local therapy choices for young women with breast cancer. Am J Surg. 2024 Oct 29;239:116060. doi: 10.1016/j.amjsurg.2024.116060. Epub ahead of print. PMID: 39500008.

Tags: Hematology/Oncology, Publications

Enfortumab Vedotin Plus Pembrolizumab in Untreated Locally Advanced or Metastatic Urothelial Carcinoma: 2.5-Year Median Follow-Up of the Phase III EV-302/KEYNOTE-A39 Trial

Powles TB, Van der Heijden MS, Loriot Y, Bedke J, Valderrama BP, Iyer G, Kikuchi E, Hoffman-Censits J, Vulsteke C, Drakaki A, Rausch S, Arafat[...]

The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study

García-Estévez L, Bardia A, Rugo HS, Carey LA, Diéras VC, Loibl S, Piccart M, Gianni L, Kalinsky K, O'Shaughnessy J, Hurvitz SA, Harting E, Valdez[...]

Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset

Nishio M, Seto T, Reck M, Garon EB, Nishio K, Kasahara K, Nishino K, Satouchi M, Yoh K, Hayashi H, Sakai K, Enatsu S, Frimodt-Møller[...]